INVO Fertility, Inc. (IVF) Stock Profile — Insider Trades & Financials

Revenue$1.8M

Net Income-$17.4M

EPS$-17.83

Market Cap$31.1M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Steven Shum

CEO & Executive Director

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the womanâs body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Founded: 2007
Employees: 35

⚡

Core Efficiency

ROE?

-521.79%

ROA?

-92.41%

D/E Ratio?

3.89

Op. Margin?

-93.08%

📊

Profitability Ratios

Net Margin?

-990.48%

Loading company sections...

INVO Fertility, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness